Patents by Inventor Mount Sinai School of Medicine of New York Unive

Mount Sinai School of Medicine of New York Unive has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DOSE ESCALATION ENZYME REPLACEMENT THERAPY FOR TREATING ACID SPHINOGMYELINASE DEFICIENCY
    Publication number: 20130078230
    Abstract: The invention relates to dose escalation enzyme replacement therapy using acid sphingomyelinase (ASM) for the treatment of human subjects having acid sphingomyelinase deficiency (ASMD), and, in particular, patients with non-neurological manifestations of Niemann-Pick Disease (NPD), and in certain embodiments, NPD type B.
    Type: Application
    Filed: November 16, 2012
    Publication date: March 28, 2013
    Applicants: Genzyme Corporation, Mount Sinai School of Medicine of New York University
    Inventors: Mount Sinai School of Medicine of New York Unive, Genzyme Corporation
  • DOSE ESCALATION ENZYME REPLACEMENT THERAPY FOR TREATING ACID SPHINOGMYELINASE DEFICIENCY
    Publication number: 20130078231
    Abstract: The invention relates to dose escalation enzyme replacement therapy using acid sphingomyelinase (ASM) for the treatment of human subjects having acid sphingomyelinase deficiency (ASMD), and, in particular, patients with non-neurological manifestations of Niemann-Pick Disease (NPD), and in certain embodiments, NPD type B.
    Type: Application
    Filed: November 16, 2012
    Publication date: March 28, 2013
    Applicants: Genzyme Corporation, Mount Sinai School of Medicine of New York University
    Inventors: Mount Sinai School of Medicine of New York Unive, Genzyme Corporation